Doximity's stock doubled in value before giving back most of its gains, leading to market skepticism about the sustainability of its rally and the company's long-term prospects.

Doximity's stock price saw a substantial increase on Friday, with an article exploring the reasons behind its rapid rise.

Doximity's stock has seen an extraordinary increase, with one article reporting a 66% surge and another a 50% jump, driven by excitement over its medical AI opportunities, though some analysts express caution about potential business cannibalization.

Doximity's stock experienced a significant plunge today, prompting investor concern regarding the company's market performance.

Doximity's stock experienced a significant 20% drop after the company issued soft guidance and cited pressures on its profit margins due to AI-related factors. This reflects investor concerns about its financial outlook.

This article contains the transcript of Doximity's earnings call for the fourth quarter of 2026.

Bank of America has reduced its price target for Doximity, Inc. (DOCS) from $56 to $47.

Doximity (DOCS) shares experienced a decline following concerns regarding potential disruption from artificial intelligence technologies.

Canaccord believes Doximity, Inc.'s (DOCS) post-earnings selloff was an overreaction and sees long-term upside for the company.

Atlassian and Doximity shares experienced a significant 30% surge following their recent earnings reports, highlighting a similar positive trend among certain software stocks.

The article summarizes the main points from Doximity's first-quarter earnings call, detailing its financial performance and business updates.

OCBC stock is surging today, while Doximity stock saw a dramatic increase of over 70% in after-hours trading on Thursday.

Doximity's stock price has fallen to an all-time low after the release of its fourth-quarter results. In response to the performance, KeyBanc has downgraded the company's stock.

Doximity projects fiscal 2027 revenue between $664 million and $676 million, citing an 'AI investment year' and reduced visibility in pharmaceutical advertising.

Doximity's stock experienced a significant decline following the release of its fourth-quarter earnings report and a weak financial outlook.

Doximity's Chief Financial Officer has resigned from their position. The company announced that the interim finance head will continue in their role.

An analysis explores whether Doximity (DOCS) is among the stocks poised for significant growth within the next three years.

Several major stocks, including Apple, Intel, GameStop, and Berkshire, are experiencing significant movements in premarket trading.

Doximity (DOCS) stock experienced a significant 40% surge after the company released its latest earnings report, prompting discussions about its future market trajectory.

Doximity stock experienced a significant drop, leading to speculation that it might be a rare chance to invest in a high-quality growth company at a reduced price.

A compilation of top research calls from Wall Street analysts for Thursday includes recommendations on companies such as Commercial Metals, Doximity, Draftkings, and Starbucks.

Doximity's earnings report is approaching, prompting analysts to revise their forecasts ahead of the company's earnings call.

An analysis suggests that Doximity (DOCS) continues to be an appealing stock for investors, highlighting reasons for its sustained attractiveness in the market.